Cheng Du Sheng Nuo Biotec Co. Ltd. A

688117 • SHG

¥24.56+¥0.51 (2.12%)

Estimate

P/E

26.7

EPS

0.92

Beta

0.55

Growth

Revenue, YoY

71.62%

Net income, YoY

64.52%

FCF, YoY

54.72%

Forecast

P/E (FWD)

19.1

EPS (FWD)

1.283

Dividends

Dividend yield

2.61%

Annual payout

¥0.64

Next ex. div date

December 5, 26

Payout

33.11%

Dividend growth streak

1 year

Div.rating

About the company

Ticker

688117

ISIN

CNE1000051M8

Country

China

Sector (GICS)

Healthcare

ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. It provides semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, degarelix, cetrorelix, plecanatide, and desmopressin acetate. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

Frequently asked questions

What sector does Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) operate in?

Cheng Du Sheng Nuo Biotec Co. Ltd. A belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) current stock price?

As of the latest data, Cheng Du Sheng Nuo Biotec Co. Ltd. A stock price is CN¥24.56, with a previous close of CN¥24.05. Cheng Du Sheng Nuo Biotec Co. Ltd. A gained CN¥0.51 in the last trading session, representing a 2.12% increase.

What is Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) current market capitalization?

Cheng Du Sheng Nuo Biotec Co. Ltd. A market cap is approximately 5.41 billion.

What is Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.92, and the forward EPS is CN¥1.28.

What is Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) Price-to-Earnings (P/E) ratio?

Cheng Du Sheng Nuo Biotec Co. Ltd. A current P/E ratio is 26.7, with a forward P/E of 19.14.

Does Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) pay dividends?

Yes. Cheng Du Sheng Nuo Biotec Co. Ltd. A pays semiannual dividends with an annualized yield of 2.61% and an estimated annual payout of CN¥0.64 per share.

When is the next ex-dividend date for Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117)?

The next ex-dividend date is scheduled for December 05, 2026.

What is Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) beta (volatility) score?

Cheng Du Sheng Nuo Biotec Co. Ltd. A has a beta of 0.550, indicating lower volatility than the overall market.